These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII). Warrington RJ, Rutherford WJ, Wong SK, Cook JM, Rector ES. J Immunol; 1989 Oct 15; 143(8):2546-52. PubMed ID: 2529311 [Abstract] [Full Text] [Related]
7. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets. Jelinek DF, Splawski JB, Lipsky PE. J Immunol; 1986 Jan 15; 136(1):83-92. PubMed ID: 3484392 [Abstract] [Full Text] [Related]
8. The effects of interleukin 1 on human B cell activation and proliferation. Falkoff RJ, Muraguchi A, Hong JX, Butler JL, Dinarello CA, Fauci AS. J Immunol; 1983 Aug 15; 131(2):801-5. PubMed ID: 6602846 [Abstract] [Full Text] [Related]
9. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation. Ambrus JL, Peters MG, Fauci AS, Brown EJ. J Immunol; 1990 Mar 01; 144(5):1549-53. PubMed ID: 2307833 [Abstract] [Full Text] [Related]
10. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells. Sherris D, Stohl W, Mayer L. J Immunol; 1989 Apr 01; 142(7):2343-51. PubMed ID: 2538506 [Abstract] [Full Text] [Related]
16. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2. Tseng CT, Springgate CF, Piela TH, Choi YS. J Immunol; 1987 Apr 15; 138(8):2554-60. PubMed ID: 3031160 [Abstract] [Full Text] [Related]
17. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation. Nakagawa T, Nakagawa N, Goldstein H, Volkman DJ, Fauci AS. J Immunol; 1986 Nov 15; 137(10):3175-82. PubMed ID: 2945860 [Abstract] [Full Text] [Related]
18. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells. Vazquez A, Auffredou MT, Gerard JP, Delfraissy JF, Galanaud P. J Immunol; 1987 Oct 01; 139(7):2344-8. PubMed ID: 3116080 [Abstract] [Full Text] [Related]
19. Human BCGF-12kD functions as an autocrine growth factor in transformed B cells. Kumar A, Vasquez A, Maizel AL, Sharma S. Eur Cytokine Netw; 1990 Oct 01; 1(2):109-13. PubMed ID: 1966378 [Abstract] [Full Text] [Related]
20. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells. Jelinek DF, Lipsky PE. J Immunol; 1987 Aug 15; 139(4):1005-13. PubMed ID: 3112218 [Abstract] [Full Text] [Related] Page: [Next] [New Search]